Its primary mechanism in a research setting involves the upregulation of the Early Growth Response-1 (EGR-1) gene
This EPO-R/CD131 selectivity allows for neuroprotection and tissue repair without the thrombotic risks of erythropoietin
It counteracts inflammation too, easing arthritis symptoms
Individual responses may vary depending on stress levels, sleep quality, inflammatory status, nutrition, skin type, and concurrent regenerative or metabolic research compounds
It has been demonstrated that low doses of ouabain (10 nM100 M) can stimulate ROS generation and NFkB activation, which is not related to inhibition of Na-K-ATPase activity nor intracellular Na + or K + concentrations (Liu et al
Nordenstrom A, Thyen U (2014) Improving the communication of healthcare professionals with affected children and adolescents